应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02142 和铂医药-B
休市中 05-17 16:08:17
1.380
-0.020
-1.43%
最高
1.470
最低
1.380
成交量
206.80万
今开
1.430
昨收
1.400
日振幅
6.43%
总市值
10.61亿
流通市值
10.61亿
总股本
7.68亿
成交额
292.35万
换手率
0.27%
流通股本
7.68亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
和铂医药-B(02142)下跌5.19%,报1.46元/股
金融界 · 05-10
和铂医药-B(02142)下跌5.19%,报1.46元/股
和铂医药-B(02142)股价下跌5.195%,现价港币$1.46
阿斯达克财经 · 05-10
和铂医药-B(02142)股价下跌5.195%,现价港币$1.46
和铂医药CEO王劲松:从病人需求出发,跃入创新药的旷野
时代周报 · 05-10
和铂医药CEO王劲松:从病人需求出发,跃入创新药的旷野
和铂医药-B(02142)上涨5.59%,报1.51元/股
金融界 · 05-09
和铂医药-B(02142)上涨5.59%,报1.51元/股
和铂医药-B盘中异动 股价大涨5.59%报1.510港元
自选股智能写手 · 05-09
和铂医药-B盘中异动 股价大涨5.59%报1.510港元
和铂医药-B(02142)上涨8.82%,报1.48元/股
金融界 · 05-06
和铂医药-B(02142)上涨8.82%,报1.48元/股
和铂医药-B盘中异动 股价大涨5.07%
自选股智能写手 · 05-06
和铂医药-B盘中异动 股价大涨5.07%
和铂医药-B盘中异动 早盘急速上涨5.50%报1.361港元
自选股智能写手 · 05-03
和铂医药-B盘中异动 早盘急速上涨5.50%报1.361港元
和铂医药-B(02142)上涨10.17%,报1.3元/股
金融界 · 05-02
和铂医药-B(02142)上涨10.17%,报1.3元/股
和铂医药-B盘中异动 股价大涨5.08%
自选股智能写手 · 05-02
和铂医药-B盘中异动 股价大涨5.08%
和铂医药-B(02142)4月30日注销175万股
智通财经网 · 04-30
和铂医药-B(02142)4月30日注销175万股
和铂医药-B盘中异动 早盘大幅拉升5.68%
自选股智能写手 · 04-29
和铂医药-B盘中异动 早盘大幅拉升5.68%
和铂医药-B盘中异动 股价大涨5.04%报1.250港元
自选股智能写手 · 04-26
和铂医药-B盘中异动 股价大涨5.04%报1.250港元
和铂医药-B(02142)股价显著上升12.5%,现价港币$1.26
阿斯达克财经 · 04-25
和铂医药-B(02142)股价显著上升12.5%,现价港币$1.26
和铂医药-B(02142)上涨6.25%,报1.19元/股
金融界 · 04-25
和铂医药-B(02142)上涨6.25%,报1.19元/股
和铂医药-B盘中异动 股价大涨6.16%
自选股智能写手 · 04-25
和铂医药-B盘中异动 股价大涨6.16%
和铂医药-B:2023年度净利润22,763千美元,较去年同期实现扭亏为盈
金融界港股 · 04-25
和铂医药-B:2023年度净利润22,763千美元,较去年同期实现扭亏为盈
和铂医药-B盘中异动 下午盘快速上涨5.46%
自选股智能写手 · 04-23
和铂医药-B盘中异动 下午盘快速上涨5.46%
和铂医药-B盘中异动 早盘股价大涨5.87%报1.101港元
自选股智能写手 · 04-22
和铂医药-B盘中异动 早盘股价大涨5.87%报1.101港元
公司概况
公司名称:
和铂医药-B
所属市场:
SEHK
上市日期:
--
主营业务:
和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括巴托利单抗,主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等;以及特那西普,主要用于干眼病。此外,该公司还研究和开发肿瘤免疫产品管线,包括内部开发的新一代肿瘤免疫资产,针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。
发行价格:
--
{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":1.38,"timestamp":1715933297029,"preClose":1.4,"halted":0,"volume":2068000,"delay":0,"floatShares":768490410,"shares":768490410,"eps":0.24230604,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"05-17 16:08:17","open":1.43,"high":1.47,"low":1.38,"amount":2923470,"amplitude":0.064286,"askPrice":1.4,"askSize":325000,"bidPrice":1.38,"bidSize":54000,"shortable":0,"etf":0,"ttmEps":0.23402894254397943,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"listingDate":1607529600000,"adjPreClose":1.4,"openAndCloseTimeList":[[1715909400000,1715918400000],[1715922000000,1715932800000]],"volumeRatio":0.8522914605684527,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142/wiki","defaultTab":"wiki","newsList":[{"id":"2434848678","title":"和铂医药-B(02142)下跌5.19%,报1.46元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434848678","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434848678?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:55","pubTimestamp":1715327725,"startTime":"0","endTime":"0","summary":"5月10日,和铂医药-B(02142)盘中下跌5.19%,截至15:55,报1.46元/股,成交392.15万元。和铂医药控股有限公司主要从事研究和开发免疫和肿瘤疾病的新型和高度差异化抗体疗法,拥有全球独家权利的和铂抗体平台是其主要技术支持。截至2020年6月30日,该公司已有六个项目进入临床阶段,和铂抗体平台已获得超过45个生物医药行业及学术界合作伙伴的认可。截至2023年年报,和铂医药-B营业总收入6.34亿元、净利润1.61亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/10155540599730.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434841958","title":"和铂医药-B(02142)股价下跌5.195%,现价港币$1.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2434841958","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2434841958?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:54","pubTimestamp":1715327640,"startTime":"0","endTime":"0","summary":"[下跌股]和铂医药-B(02142) 股价在下午03:54比前收市价下跌5.195%,现股价为港币$1.46。至目前为止,今日最高价为$1.58,而最低价为$1.46。总成交量为257.3万股,总成交金额为港币$387.003万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2405102404/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2434502075","title":"和铂医药CEO王劲松:从病人需求出发,跃入创新药的旷野","url":"https://stock-news.laohu8.com/highlight/detail?id=2434502075","media":"时代周报","top":-1,"share":"https://www.laohu8.com/m/news/2434502075?lang=zh_cn&edition=full","pubTime":"2024-05-10 09:00","pubTimestamp":1715302801,"startTime":"0","endTime":"0","summary":"2016年,王劲松从老东家赛诺菲辞职,创立和铂医药。和铂医药创始人、董事长兼CEO王劲松。10个月后,和铂医药迎来年内第二项对外授权合作。2020年赴港股上市时,和铂医药的管线已经拓展到11款。开源节流,是王劲松给这场改革制定的策略。一天后,和铂医药又宣布与药明生物控股子公司药明海德订立资产转让协议,出售生物大分子研发创新中心项目的生产厂房。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510090027874e4b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510090027874e4b10&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434649080","title":"和铂医药-B(02142)上涨5.59%,报1.51元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434649080","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434649080?lang=zh_cn&edition=full","pubTime":"2024-05-09 10:01","pubTimestamp":1715220105,"startTime":"0","endTime":"0","summary":"5月9日,和铂医药-B(02142)盘中上涨5.59%,截至10:01,报1.51元/股,成交117.78万元。和铂医药控股有限公司主要从事研究和开发免疫和肿瘤疾病的新型和高度差异化抗体疗法,拥有全球独家权利的和铂抗体平台是其主要技术支持。截至2020年6月30日,该公司已有六个项目进入临床阶段,和铂抗体平台已获得超过45个生物医药行业及学术界合作伙伴的认可。截至2023年年报,和铂医药-B营业总收入6.34亿元、净利润1.61亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/09100140577070.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434003896","title":"和铂医药-B盘中异动 股价大涨5.59%报1.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434003896","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434003896?lang=zh_cn&edition=full","pubTime":"2024-05-09 10:01","pubTimestamp":1715220099,"startTime":"0","endTime":"0","summary":"2024年05月09日早盘10时01分,和铂医药-B股票出现异动,股价大幅拉升5.59%。截至发稿,该股报1.510港元/股,成交量79.2万股,换手率0.10%,振幅3.50%。资金方面,该股资金流入92.592万港元,流出17.978万港元。和铂医药-B股票所在的生物技术行业中,整体涨幅为1.62%。其相关个股中,再鼎医药、圣诺医药-B、百济神州涨幅较大,振幅较大的相关个股有圣诺医药-B、再鼎医药、北海康成-B,振幅分别为13.43%、13.37%、12.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509100139861ebf42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509100139861ebf42&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433618864","title":"和铂医药-B(02142)上涨8.82%,报1.48元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433618864","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2433618864?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:44","pubTimestamp":1714959852,"startTime":"0","endTime":"0","summary":"5月6日,和铂医药-B(02142)盘中上涨8.82%,截至09:44,报1.48元/股,成交100.73万元。和铂医药控股有限公司主要从事研究和开发免疫和肿瘤疾病的新型和高度差异化抗体疗法,拥有全球独家权利的和铂抗体平台是其主要技术支持。截至2020年6月30日,该公司已有六个项目进入临床阶段,和铂抗体平台已获得超过45个生物医药行业及学术界合作伙伴的认可。截至2023年年报,和铂医药-B营业总收入6.34亿元、净利润1.61亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/06094440522795.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433053469","title":"和铂医药-B盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433053469","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433053469?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:36","pubTimestamp":1714959360,"startTime":"0","endTime":"0","summary":"2024年05月06日早盘09时36分,和铂医药-B股票出现异动,股价快速拉升5.07%。和铂医药-B股票所在的生物技术行业中,整体跌幅为0.25%。其相关个股中,和铂医药-B、再鼎医药、泰格医药涨幅较大,振幅较大的相关个股有乐普生物-B、三叶草生物-B、宜明昂科-B,振幅分别为12.01%、8.05%、5.69%。和铂医药-B公司简介:和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506093600861eaf5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506093600861eaf5f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432964489","title":"和铂医药-B盘中异动 早盘急速上涨5.50%报1.361港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432964489","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432964489?lang=zh_cn&edition=full","pubTime":"2024-05-03 09:34","pubTimestamp":1714700068,"startTime":"0","endTime":"0","summary":"2024年05月03日早盘09时34分,和铂医药-B股票出现异动,股价快速上涨5.50%。截至发稿,该股报1.361港元/股,成交量22.3万股,换手率0.03%,振幅2.33%。资金方面,该股资金流入24.607万港元,流出3.858万港元。和铂医药-B股票所在的生物技术行业中,整体跌幅为0.14%。其相关个股中,和铂医药-B、圣诺医药-B、科济药业-B涨幅较大,振幅较大的相关个股有圣诺医药-B、基石药业-B、泰格医药,振幅分别为11.63%、6.42%、6.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030934287925b93b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030934287925b93b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432061060","title":"和铂医药-B(02142)上涨10.17%,报1.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432061060","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432061060?lang=zh_cn&edition=full","pubTime":"2024-05-02 13:39","pubTimestamp":1714628363,"startTime":"0","endTime":"0","summary":"5月2日,和铂医药-B(02142)盘中上涨10.17%,截至13:39,报1.3元/股,成交163.94万元。和铂医药控股有限公司主要从事研究和开发免疫和肿瘤疾病的新型和高度差异化抗体疗法,拥有全球独家权利的和铂抗体平台是其主要技术支持。截至2020年6月30日,该公司已有六个项目进入临床阶段,和铂抗体平台已获得超过45个生物医药行业及学术界合作伙伴的认可。截至2023年年报,和铂医药-B营业总收入6.34亿元、净利润1.61亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/02133940509620.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432695409","title":"和铂医药-B盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432695409","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432695409?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:53","pubTimestamp":1714614802,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘09时53分,和铂医药-B股票出现波动,股价急速拉升5.08%。截至发稿,该股报1.240港元/股,成交量37万股,换手率0.05%,振幅4.24%。和铂医药-B股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,科笛-B、加科思-B、北海康成-B涨幅较大,振幅较大的相关个股有科笛-B、创胜集团-B、加科思-B,振幅分别为6.69%、6.08%、5.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020953227925a9ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020953227925a9ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431431432","title":"和铂医药-B(02142)4月30日注销175万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431431432","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2431431432?lang=zh_cn&edition=full","pubTime":"2024-04-30 19:00","pubTimestamp":1714474839,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和铂医药-B(02142)公布,2024年4月30日注销175万股已回购股份。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116409.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431042078","title":"和铂医药-B盘中异动 早盘大幅拉升5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431042078","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431042078?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:51","pubTimestamp":1714355485,"startTime":"0","endTime":"0","summary":"2024年04月29日早盘09时51分,和铂医药-B股票出现波动,股价急速拉升5.68%。截至发稿,该股报1.321港元/股,成交量20.1万股,换手率0.03%,振幅4.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。和铂医药-B股票所在的生物技术行业中,整体涨幅为0.85%。其相关个股中,来凯医药-B、乐普生物-B、金斯瑞生物科技涨幅较大,振幅较大的相关个股有来凯医药-B、宜明昂科-B、科笛-B,振幅分别为11.49%、9.40%、9.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909512587e84774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909512587e84774&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430529360","title":"和铂医药-B盘中异动 股价大涨5.04%报1.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430529360","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430529360?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:46","pubTimestamp":1714096019,"startTime":"0","endTime":"0","summary":"2024年04月26日早盘09时46分,和铂医药-B股票出现异动,股价快速拉升5.04%。截至发稿,该股报1.250港元/股,成交量9.9万股,换手率0.01%,振幅4.20%。资金方面,该股资金流入9.685万港元,流出2.42万港元。和铂医药-B股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,泰格医药、维亚生物、乐普生物-B涨幅较大,振幅较大的相关个股有泰格医药、维亚生物、乐普生物-B,振幅分别为9.84%、7.14%、5.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426094659861e9469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426094659861e9469&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430742441","title":"和铂医药-B(02142)股价显著上升12.5%,现价港币$1.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2430742441","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430742441?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:35","pubTimestamp":1714030500,"startTime":"0","endTime":"0","summary":"[上升股]和铂医药-B(02142) 股价在下午03:35比前收市价显著上升12.5%,现股价为港币$1.26。至目前为止,今日最高价为$1.26,而最低价为$1.11。总成交量为156.8万股,总成交金额为港币$186.538万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404252542/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2430428744","title":"和铂医药-B(02142)上涨6.25%,报1.19元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430428744","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430428744?lang=zh_cn&edition=full","pubTime":"2024-04-25 14:07","pubTimestamp":1714025266,"startTime":"0","endTime":"0","summary":"4月25日,和铂医药-B(02142)盘中上涨6.25%,截至14:07,报1.19元/股,成交115.48万元。和铂医药控股有限公司主要从事研究和开发免疫和肿瘤疾病的新型和高度差异化抗体疗法,拥有全球独家权利的和铂抗体平台是其主要技术支持。截至2020年6月30日,该公司已有六个项目进入临床阶段,和铂抗体平台已获得超过45个生物医药行业及学术界合作伙伴的认可。截至2023年年报,和铂医药-B营业总收入6.34亿元、净利润1.61亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/25140740402033.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430428934","title":"和铂医药-B盘中异动 股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430428934","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430428934?lang=zh_cn&edition=full","pubTime":"2024-04-25 13:47","pubTimestamp":1714024048,"startTime":"0","endTime":"0","summary":"2024年04月25日下午盘13时47分,和铂医药-B股票出现异动,股价急速拉升6.16%。截至发稿,该股报1.190港元/股,成交量43.4万股,换手率0.06%,振幅7.14%。资金方面,该股资金流入26.925万港元,流出16.515万港元。和铂医药-B股票所在的生物技术行业中,整体涨幅为0.75%。其相关个股中,维亚生物、腾盛博药-B、科济药业-B涨幅较大,振幅较大的相关个股有科济药业-B、来凯医药-B、腾盛博药-B,振幅分别为16.04%、15.76%、15.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251347287a557c36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251347287a557c36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430441808","title":"和铂医药-B:2023年度净利润22,763千美元,较去年同期实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2430441808","media":"金融界港股","top":-1,"share":"https://www.laohu8.com/m/news/2430441808?lang=zh_cn&edition=full","pubTime":"2024-04-25 07:10","pubTimestamp":1714000211,"startTime":"0","endTime":"0","summary":"金融界4月25日消息,和铂医药-B在2023年度年报中公布,公司年内净利润为22,763千美元,相较于2022年度的净亏损137,268千美元实现扭亏为盈。与此同时,该公司在2023年度的收入为89,502千美元,大幅较2022年度增长达一倍以上。综合看来,和铂医药-B在2023财年中的经营情况明显改善。2023年度,和铂医药-B多个研发项目取得标志性进展,例如:药物HBM9161、HBM4003多次在临床试验中取得积极结果。以上数据未经审核。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/25071040395799.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429159015","title":"和铂医药-B盘中异动 下午盘快速上涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429159015","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429159015?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:05","pubTimestamp":1713855937,"startTime":"0","endTime":"0","summary":"2024年04月23日下午盘15时05分,和铂医药-B股票出现异动,股价快速拉升5.46%。截至发稿,该股报1.140港元/股,成交量130.5万股,换手率0.17%,振幅8.33%。资金方面,该股资金流入66.104万港元,流出62.892万港元。和铂医药-B股票所在的生物技术行业中,整体涨幅为1.45%。其相关个股中,北海康成-B、来凯医药-B、康诺亚-B涨幅较大,振幅较大的相关个股有北海康成-B、来凯医药-B、康诺亚-B,振幅分别为31.25%、20.04%、11.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423150537861e81dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423150537861e81dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429086964","title":"和铂医药-B盘中异动 早盘股价大涨5.87%报1.101港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429086964","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429086964?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:02","pubTimestamp":1713751344,"startTime":"0","endTime":"0","summary":"2024年04月22日早盘10时02分,和铂医药-B股票出现波动,股价大幅上涨5.87%。截至发稿,该股报1.101港元/股,成交量37.8万股,换手率0.05%,振幅5.77%。资金方面,该股资金流入37.354万港元,流出3.076万港元。和铂医药-B股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,亚盛医药-B、再鼎医药、金斯瑞生物科技涨幅较大,振幅较大的相关个股有科笛-B、金斯瑞生物科技、亚盛医药-B,振幅分别为9.06%、6.90%、6.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042210022487e825d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042210022487e825d2&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0612},{"period":"1month","weight":0.2661},{"period":"3month","weight":-0.1636},{"period":"6month","weight":-0.1375},{"period":"1year","weight":-0.2333},{"period":"ytd","weight":-0.2887}],"compareEarnings":[{"period":"1week","weight":0.0311},{"period":"1month","weight":0.2032},{"period":"3month","weight":0.1967},{"period":"6month","weight":0.1203},{"period":"1year","weight":-0.0088},{"period":"ytd","weight":0.147}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括巴托利单抗,主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等;以及特那西普,主要用于干眼病。此外,该公司还研究和开发肿瘤免疫产品管线,包括内部开发的新一代肿瘤免疫资产,针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111525},{"month":2,"riseRate":0,"avgChangeRate":-0.110405},{"month":3,"riseRate":0.25,"avgChangeRate":-0.124902},{"month":4,"riseRate":0.5,"avgChangeRate":0.027757},{"month":5,"riseRate":0.5,"avgChangeRate":0.024026},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.075046},{"month":7,"riseRate":0.333333,"avgChangeRate":0.014432},{"month":8,"riseRate":0,"avgChangeRate":-0.133385},{"month":9,"riseRate":0,"avgChangeRate":-0.201551},{"month":10,"riseRate":0,"avgChangeRate":-0.200739},{"month":11,"riseRate":1,"avgChangeRate":0.440588},{"month":12,"riseRate":0.666667,"avgChangeRate":0.280942}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}